Novel Findings of Polypoidal Choroidal Vasculopathy via Optical Coherence Tomography Angiography

다국어 초록 (Multilingual Abstract)

Purpose: To introduce novel findings of polypoidal choroidal vasculopathy (PCV) via optical coherence tomographyangiography (OCTA)Methods: This study is a retrospective chart review of 16 patients (16 eyes) with PCV. OCTA (Avanti RTVue XR)findings were evaluated and selected for analysis after agreement by two retina specialists .
Results: Twenty one polyps in 16 eyes (16 patients) with PCV were included in this study. The mean patientage was 67 years (13 men and three women). The shape of polypoidal lesions on OCTA at initial were halo(five polyps), rosette (seven polyps), and vascular network (nine polyps). Eight months after anti-vascular endothelialgrowth factor treatment, in a total of four eyes, seven polyps could be followed up completely, thetwo halo type polypoidal lesions changed to rosette and vascular network type. The lesions of three rosetteand two vascular network type lesions did not change in shape. In addition, the size of the polypoidal lesions(one among two halo types, two among three rosette types, and two among two vascular network types) decreased,but one halo type did not change and one rosette type increased in size on OCTA.
Conclusions: En-face OCTA enabled us to categorize novel types of PCV with polypoidal lesions.

참고문헌 (Reference)

1 이지웅, "한국인에 있어서 결절맥락막혈관병증의 역학과 임상소견" 대한안과학회 48 (48): 63-74, 2007

2 Spaide RF, "Treatment of polypoidal choroidal vasculopathy with photodynamic therapy" 22 : 529-535, 2002

3 Yannuzzi LA, "The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy" 115 : 478-485, 1997

4 Inoue M, "Shortterm efficacy of intravitreal aflibercept in treatment-naive patients with polypoidal choroidal vasculopathy" 34 : 2178-2184, 2014

5 Ijiri S, "Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy" 253 : 351-357, 2015

6 Li X, "Retina" Mosby 1285-1290, 2013

7 Tateiwa H, "Polypoidal choroidal vasculopathy with large vascular network" 240 : 354-361, 2002

8 Wen F, "Polypoidal choroidal vasculopathy in elderly Chinese patients" 242 : 625-629, 2004

9 Silva RM, "Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin" 243 : 973-979, 2005

10 Uyama M, "Polypoidal choroidal vasculopathy : natural history" 133 : 639-648, 2002

11 Koh AH, "Polypoidal choroidal vasculopathy : evidence-based guidelines for clinical diagnosis and treatment" 33 : 686-716, 2013

12 Inoue M, "Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization" 35 : 2265-2274, 2015

13 Kim JY, "Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy" 254 : 1505-1510, 2016

14 Srour M, "Optical coherence tomography angiography characteristics of polypoidal cho-roidal vasculopathy" 100 : 1489-1493, 2016

15 Yamamoto A, "One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy" 122 : 1866-1872, 2015

16 Miura M, "Noninvasive vascular imaging of polypoidal choroidal vasculopathy by Doppler optical coherence tomography" 56 : 3179-3186, 2015

17 Spaide RF, "Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy" 15 : 100-110, 1995

18 Schneider U, "Indocyanine green angiography and idiopathic polypoidal choroidal vasculopathy" 82 : 98-99, 1998

19 Ojima Y, "Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography" 29 : 52-59, 2009

20 Yannuzzi LA, "Idiopathic polypoidal choroidal vasculopathy(IPCV)" 10 : 1-8, 1990

21 Uyama M, "Idiopathic polypoidal choroidal vasculopathy in Japanese patients" 117 : 1035-1042, 1999

22 Wang M, "Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography" 57 : OCT526-OCT532, 2016

23 Gomi F, "Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy" 92 : 70-73, 2008

24 Koh A, "EVEREST study : efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy" 32 : 1453-1464, 2012

25 Kokame GT, "Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy : 6-month results" 94 : 297-301, 2010

26 Takayama K, "Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy" 31 : 45-52, 2017

27 Tanaka K, "Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy" 101 : 51-55, 2017

28 Cheung CM, "Characterization and differentiation of polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography" 37 : 1464-1474, 2017

29 Tomiyasu T, "Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography" 57 : OCT324-OCT330, 2016

30 Wong CW, "Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians" 53 : 107-139, 2016